↓ Skip to main content

Metformin: a case of divide and conquer

Overview of attention for article published in Breast Cancer Research, March 2013
Altmetric Badge

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Metformin: a case of divide and conquer
Published in
Breast Cancer Research, March 2013
DOI 10.1186/bcr3387
Pubmed ID
Authors

Dimitrios Anastasiou

Abstract

Metformin is a widely prescribed anti-diabetic drug and its use is associated with lower cancer incidence. The mechanisms by which metformin attenuates tumorigenesis are not clearly understood. In a paper published in Proceedings of the National Academy of Sciences of the United States of America, Hirsch and colleagues show that metformin interferes with a signaling pathway, mediated by the transcription factor NF-κB, which drives cell transformation and is required for the maintenance of cancer stem cells.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 8%
Unknown 11 92%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 17%
Researcher 2 17%
Student > Ph. D. Student 2 17%
Other 1 8%
Professor > Associate Professor 1 8%
Other 1 8%
Unknown 3 25%
Readers by discipline Count As %
Medicine and Dentistry 5 42%
Agricultural and Biological Sciences 2 17%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Computer Science 1 8%
Unknown 3 25%